Pharmacological MRI: a biomarker in CNS drug discovery and development?

被引：0
|
作者：
Lucignani, Giovanni
Bastianello, Stefano
机构：
[1] Univ Milan, Inst Radiol Sci, I-820142 Milan, Italy
[2] San Paolo Hosp, Unit Nucl Med, Milan, Italy
[3] Univ Pavia, IRCCS C Mondino Inst Neurol Fdn, Neuradiol Unit, I-27100 Pavia, Italy
来源：
FUNCTIONAL NEUROLOGY | 2007年 / 22卷 / 02期
关键词：
BRAIN;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：71 / 73
页数：3
相关论文
共 50 条
  • [31] Polymerase Chain Reaction Chips for Biomarker Discovery and Validation in Drug Development
    Vo, Dang-Khoa
    Trinh, Kieu The Loan
    MICROMACHINES, 2025, 16 (03)
  • [32] New Horizons in Biomarker Discovery: Assay Technologies for Personalized Drug Development
    Singh, Dilpreet
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2025,
  • [33] Lipid tracing and metabolic flux for translatable biomarker development in drug discovery
    Roddy, Thomas P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [34] Has the Time Come for Predictive Computer Modeling in CNS Drug Discovery and Development?
    Geerts, H.
    Spiros, A.
    Roberts, P.
    Carr, R.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2012, 1 (11):
  • [35] Calibration of MRI as a truly quantitative biomarker for neuroinflammation and myelination in drug development
    Zehnder, Tamara
    Bruns, Andreas
    Gustinelli, Alessandro
    Foo, Lynette
    Kuennecke, Basil
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 534 - 535
  • [36] Development and construction of an original compound library for CNS drug discovery: Combining computational and wet data to enhance CNS drug-likeness
    Hasegawa, Daiju
    Graczyk, Piotr
    Nicewonger, Robert
    Bhatia, Gurpreet
    Birch, Louise
    Dimopoulos, Paschalis
    Payne, Andrew
    Kobayashi, Yoshihisa
    Terauchi, Taro
    Clark, Richard
    Suzuki, Shuichi
    Watanabe, Misako
    Nishioka, Tomoki
    Terauchi, Hiroki
    Ozaki, Shunsuke
    Kushida, Ikuo
    Suh, Ted
    Yu, Melvin
    Benayoud, Farid
    Sanders, Kristen
    Fang, Frank
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [37] Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study
    Simon Loiodice
    Wilhelmus H. Drinkenburg
    Abdallah Ahnaou
    Andrew McCarthy
    Geoffrey Viardot
    Emilie Cayre
    Bertrand Rion
    Valérie Bertaina-Anglade
    Marsel Mano
    Philippe L’Hostis
    Christophe Drieu La Rochelle
    Martien J. Kas
    Philippe Danjou
    Translational Psychiatry, 11
  • [38] Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study
    Loiodice, Simon
    Drinkenburg, Wilhelmus H.
    Anhaou, Abdellah
    McCarthy, Andrew
    Viardot, Geoffrey
    Cayre, Emilie
    Rion, Bertrand
    Bertaina-Anglade, Valerie
    Mano, Marsel
    L'Hostis, Philippe
    Drieu La Rochelle, Christophe
    Kas, Martien J.
    Danjou, Philippe
    TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
  • [39] Drug discovery and evaluation pharmacological assays
    Stanford, SC
    ADDICTION BIOLOGY, 1999, 4 (01) : 100 - 100
  • [40] Multinuclear MRI in Drug Discovery
    Bartusik-Aebisher, Dorota
    Bober, Zuzanna
    Zalejska-Fiolka, Jolanta
    Kawczyk-Krupka, Aleksandra
    Aebisher, David
    MOLECULES, 2022, 27 (19):
12345